= 27d567bc2d48d9f40e9ccc20ea370b15)
ChristianKl comments on The Growth of My Pessimism: Transhumanism, Immortalism, Effective Altruism. - Less Wrong Discussion
You are viewing a comment permalink. View the original post to see all comments and the full post content.
= 783df68a0f980790206b9ea87794c5b6)
Loading…= b715d02e85f7b3b4ae65ca3d3e450868)
Subscribe to RSS Feed
Powered by Reddit
= f037147d6e6c911a85753b9abdedda8d)
You are viewing a comment permalink. View the original post to see all comments and the full post content.
Comments (74)
I'm not sure whether "money directly invested in anti-aging" is a good way to think about aging. To make process on the problem we need to advance biologic research itself. We made a lot of progress by building cheap DNA sequencing. In addition to human DNA. Theranos sells medical tests at half the price of medicare reinbursement as their starting price. As time goes on I expect blood tests get a lot cheaper than they are now.
When it comes to labwork Emerald Cloud Lab and companies with a similar model can make it cheaper and make science more effective in the process.
In the QS space a lot of companies work on creating better measurement devices. Apple wants to do more in health.
They've had a very bad six weeks.
There a lot money at stake in fighting them. She lobbies for Medicare paying companies less money for tests. There are companies losing billions of dollars, so they hire PR to fight Theranos.
That's not an unexpected development. You don't change the status quo without making enemies.
They're honestly quite possibly just bullshitting about their grand plans. Theranos, that is. I wouldn't be surprised if they had some interesting ideas that they are utterly unprepared to follow through on and that they are massively overselling the importance and quality of.
Why would a company who doesn't trust into it's tech working explicitely lobby the FDA to test their products to make sure that the marketplace trusts them?
I don't think there a good reason that blood testing roughly didn't change much in price in the last 10 years while DNA sequencing got 10,000 as cheap. We good cheaper DNA sequencing because multiple companies focused on radically improving sequencing technology.
Having a direct to consumer marketplace where people know the price of testing before they buy it is likely very useful for the field to produce price competition that leads to the development of cheaper testing.
We don't need the price improvement of sequencing for blood test but having moore's law for it or half of moore's law would be a game changer. Do you think there are basic reasons why blood testing shouldn't be able to radically improve in price over time?